Sam Azoulay
Fortuna: 886 978 $ al 31/08/2026
Fortuna: 886 978 $ al 31/08/2026
Salomon Azoulay currently works at MBX Biosciences, Inc., as Chief Medical Officer from 2024.
Dr. Azoulay also formerly worked at Pfizer Essential Health, as Chief Medical Officer from 2013 to 2018, Sumitomo Pharma UK Holdings Ltd., as Chief Medical Officer from 2021 to 2023, and Roivant Sciences, Inc., as Chief Medical Officer from 2018 to 2020.
Dr. Azoulay received his undergraduate degree and doctorate degree from Sorbonne Université.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MBX BIOSCIENCES, INC. 0,03 % | 04/08/2026 | 14.399 ( 0,03 % ) | 886 978 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MBX BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Director Técnico/Científico/I+D | 01/07/2023 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Director Técnico/Científico/I+D | 01/12/2020 |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Técnico/Científico/I+D | 01/05/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Sorbonne Université
Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.